Visceral leishmaniasis control: A public health perspective

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 94, Issue 5, 2000, Pages 465-471

  Boelaert, M ^a,c   Criel, B ^a   Leeuwenburg, J ^b   Van Damme, W ^a   Le Ray, D ^c   Van Der Stuyft, P ^a  

^a Department of Public Health ^*  (Belgium)

^b Regional Public Health Service   (Netherlands)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

Chemotherapy; Clinical aspects; Diagnosis; Disease control; Epidemiology; Transmission; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTIFUNGAL AGENT; ANTIPARASITIC AGENT; ATOVAQUONE; DNA; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MILTEFOSINE; PARASITE ANTIBODY; PAROMOMYCIN; PYRROLE DERIVATIVE; RECOMBINANT GAMMA INTERFERON; STIBOGLUCONATE SODIUM; VACCINE;

AGGLUTINATION TEST; ALGORITHM; ARTHRALGIA; CARDIOTOXICITY; CLINICAL FEATURE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; FATALITY; FEVER; GEOGRAPHIC DISTRIBUTION; HEALTH CARE DELIVERY; HUMAN; HYPERGAMMAGLOBULINEMIA; LEISHMANIA DONOVANI; MYALGIA; NAUSEA; NEPHROTOXICITY; NONHUMAN; PANCREATITIS; PANCYTOPENIA; PARASITE CONTROL; PARASITE TRANSMISSION; PARASITE VECTOR; PHLEBOTOMUS; PROTOZOON; PSYCHODIDAE; PUBLIC HEALTH SERVICE; REVIEW; SERODIAGNOSIS; SPLENOMEGALY; VISCERAL LEISHMANIASIS; VOMITING; ZOONOSIS;

ANIMALIA; LEISHMANIA DONOVANI; NASO HEXACANTHUS; PROTOZOA; PSYCHODIDAE;

EID: 0033790205     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-9203(00)90055-5     Document Type: Review

References (102)

1. Potential of a direct agglutination test (DAT) for detection of visceral leishmaniasis in a known endemic area in Sudan
2. Le kala-azar au Portugal. III. Resultats d'une enquete sur la leishmaniose canine realisee dans les environs de Lisbonne. Comparaison des zones urbaines et rurales
3. Ten years of kala-azar in West Bengal, Part I. Did post-kala-azar dermal leishmaniasis initiate the outbreak in 24-Parganas?
4. Detection of Leishmania in the blood of early kala-azar patients with the aid of the polymerase chain reaction
5. Visceral leishmaniasis in Ethiopia. IV. Prevalence, incidence and relation of infection to disease in an endemic area
6. A direct agglutination test for leishmaniasis
7. Estimation of population at risk of infection and number of cases of leishmaniasis
8. New perspectives on a subclinical form of visceral leishmaniasis
9. Treatment of visceral leishmaniasis with pentavalent antimony and interferon gamma
10. Safety and efficacy of high-dose sodium stibogluconate therapy of American cutaneous leishmaniasis
11. Chemotherapy for leishmaniasis: Biochemical mechanisms, clinical efficacy, and future strategies
12. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
13. Diagnostic PCR with Leishmania donovani specificity
14. Operational validation of the direct agglutination test (DAT) for diagnosis of visceral leishmaniasis
15. Multi-centre evaluation of repeatability and reproducibility of the direct agglutination test for visceral leishmaniasis
16. The cost-effectiveness of competing diagnostic-therapeutic strategies for visceral leishmaniasis
17. A new form of cutaneous leishmaniasis-dermal leishmanoid
18. Leishmaniasis
19. Leishmaniasis in the Sudan republic. XXI. Infection in American personnel
20. Malnutrition as a risk factor for severe visceral leishmaniasis
21. Applicability of direct agglutination test (DAT) at a rural health setting in Bangladesh and feasibility of local antigen production
22. Prevalence of agglutinating anti-Leishmania antibodies in two multi-thousand Bengoli communities
23. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis
24. Electro-cardiographic changes during treatment of leishmaniasis with pentavalent antimony (sodium stibogluconate)
25. Activation of latent kala-azar and malaria by battle experience
26. A killing disease epidemic among displaced Sudanese population identified as visceral leishmaniasis
27. Visceral leishmaniasis and AIDS
28. Leishmaniasis or AIDS?
29. Leishmaniasis and world health
30. Human leishmaniases: Epidemiology and public health aspects
31. Leishmaniasis. Public health aspects and control
32. Leishmaniasis epidemiology: The theory catches up
33. Earthquakes, influenza and cycles of Indian kala-azar
34. A simple and economical direct agglutination test for serodiagnosis and sero-epidemiological studies of visceral leishmaniasis
35. Visceral leishmaniasis in Bangladesh: The value of DAT as a diagnostic tool
36. Evidence for active transmission of visceral leishmaniasis within a village in eastern Sudan
37. Protective efficacy of lambdacyhalothrin-impregnated bednets against Phlebotomus orientalis, the vector of visceral leishmaniasis in Sudan
38. A comparison of the direct agglutination test and enzyme-linked immunosorbent assay in the sero-diagnosis of leishmaniasis in the Sudan
39. Epidemiology of visceral leishmaniasis in northeast Brazil
40. Visceral leishmaniasis in immunocompromised hosts
41. Cost-effectiveness analysis of humanitarian relief interventions: Visceral leishmaniasis treatment in the Sudan
42. Recent advances in visceral leishmaniasis in China
43. Pre- and post-treatment antibody levels in visceral leishmaniasis
44. An outbreak of acute kala-azar in a nomadic tribe in western Sudan: Features of the disease in a previously non-immune population
45. Prevalence and disease spectrum in a new focus of visceral leishmaniasis in Kenya
46. Leishmaniasis in the Sudan republic. 30. Final epidemiological report
47. Miltefosine, an oral agent for the treatment of Indian visceral leishmaniasis
48. Splenic aspiration: Experience in Kenya
49. Serodiagnosis of leishmaniasis
50. Impact of DDT indoor residual spraying on Phlebotomus argentipes in a kala-azar endemic village in eastern uttar pradesh
51. Treatment of visceral leishmaniasis with sodium stibogluconate in Sudan: Management of those who do not respond
52. Protection of dogs from bites of phlebotomine sandflies by deltamethrin collars for control of canine leishmaniasis
53. The Brazilian leishmaniasis control program
54. Visceral infection caused by Leishmania tropica in veterans of operation desert storm
55. A card-agglutination test with stained trypanosomes (C.A.T.T.) for the serological diagnosis of T.b. gambiense trypanosomiasis
56. Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases
57. A primary skin lesion in visceral leishmaniasis
58. Recent research on kala-azar in East Africa
59. Mucosal leishmaniasis ('espundia' Escomel, 1911)
60. Leish-KIT, a stable direct agglutination test based on freeze-dried antigen for serodiagnosis of visceral leishmaniasis
61. Visceral leishmaniasis in patients infected with human immunodeficiency virus. Co-operative group for the study of Leishmaniasis in AIDS
62. Recurrence of kala-azar after PKDL: Role of co-factors
63. Immunotherapy for parasitic disease
64. Diagnosis of symptomatic visceral leishmaniasis by use of the polymerase chain reaction on patient blood
65. Congenital visceral leishmaniasis: Case report
66. Clinical spectrum of leishmaniasis
67. La leishmaniose viscerale: A propos d'une observation
68. Treatment of post-kala-azar dermal leishmaniasis
69. Post-kala-azar dermal leishmaniasis
70. Early phases of an outbreak of kala-azar in the Southern Fung
71. Visceral leishmaniasis control in India through primary health care system-a successful experiment of district level planning
72. A prospective sero-epidemiological study of visceral leishmaniasis in Baringo District, Rift Valley Province, Kenya
73. Visceral leishmaniasis in southern Sudan: Status of healthy villagers in epidemic conditions
74. The epidemic of visceral leishmaniasis in western upper Nile, southern Sudan: Course and impact from 1984 to 1994
75. Visceral leishmaniasis in the Sudan: Comparative parasitological methods of diagnosis
76. Evaluation of the direct agglutination test as an immunodiagnostic tool for kala-azar in India
77. Comparative evaluation of serological tests in Indian kala-azar
78. Immunochemotherapy for visceral leishmaniasis: A controlled pilot trial of antimony versus antimony plus interferon-gamma
79. An epidemic of kala-azar in the upper nile province of the Anglo-Egyptian Sudan
80. Successful treatment of refractory visceral leishmaniasis in India using antimony plus interferon-gamma
81. Circulating T helper 1 (Th1) cell- and Th2 cell-associated cytokines in Indian patients with visceral leishmaniasis
82. Rapid accurate field diagnosis of Indian visceral leishmaniasis
83. Response to interferon-gamma plus pentavalent antimony in Indian visceral leishmaniasis
84. Trial of oral miltefosine for visceral leishmaniasis
85. Leishmaniasis acquired by contagion
86. Control of zoonotic visceral leishmaniasis: Is it time to change strategies?
87. A kala-azar control programme for remote tribal communities
88. Chemotherapy of leishmaniasis and trypanosomiasis
89. Leishmania/HIV co-infection
90. Endemic disease and development: The leishmaniases
91. Direct agglutination test for diagnosis and sero-epidemiological survey of kala-azar in the Sudan
92. Kala-azar: A comparative study of parasitological methods and the direct agglutination test in diagnosis
93. Endemic kala-azar in eastern Sudan: A longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis
94. Endemic kala-azar in eastern Sudan: Post-kala-azar dermal leishmaniasis
95. The direct agglutination test for diagnosis of visceral leishmaniasis under field conditions in Sudan: Comparison of aqueous and freeze-dried antigens